CAA Gene: Colicin A Structure and Polyglutamine Roles
By Dr. Zubair Khalid, DVM, MS, PhD ·

Key Takeaways
- The
caagene encodes colicin A, a plasmid-borne bacteriocin with potent pore-forming activity, crucial for understanding bacterial outer membrane translocation and voltage-gated ion channel formation. - In eukaryotes, the trinucleotide motif CAA (encoding glutamine) is a critical element in genes like ATXN2, TBP, and HTT, where its interruptions within polyglutamine tracts are associated with neurodegenerative disorders such as Spinocerebellar Ataxia and Huntington's disease.
- Colicin A's mechanism involves high-affinity binding to the BtuB receptor, followed by translocation via OmpF and TolB, culminating in pH-triggered membrane insertion and pore formation, leading to bacterial cell death.
- CAA fungicide resistance in oomycetes is conferred by specific mutations in the cellulose synthase 3 (CesA3) gene, such as G1105S/V, which can be detected using digital droplet PCR (ddPCR) and allele-specific PCR for resistance monitoring in agriculture.
- Adenovirus E1A protein represses MHC class I gene expression via a CAA repeated element in the H-2Kb promoter, a mechanism involving histone deacetylase recruitment and chromatin condensation for immune evasion.
- The circulating anodic antigen (CAA) of Schistosoma species is a highly sensitive diagnostic biomarker for active schistosome infections, detectable with high specificity in urine and serum via ELISA or lateral flow assays.
Executive Summary & Key Metadata
The caa gene, historically designated as the structural gene for colicin A in Citrobacter freundii and Escherichia coli, encodes a plasmid-borne bacteriocin with potent pore-forming activity. The gene product, colicin A, is a paradigm for studying protein translocation across the outer membrane, receptor recognition, and voltage-gated ion channel formation. Beyond its prokaryotic significance, the trinucleotide sequence "CAA" (coding for glutamine) appears as a critical genetic element in numerous eukaryotic contexts, including trinucleotide repeat disorders, codon usage bias, and tRNA biology. This manual focuses on the canonical caa gene (colicin A structural gene) while integrating the broader biological implications of CAA-encoded glutamine tracts in human disease.
| Attribute | Value |
|---|---|
| HGNC Symbol | caa (colicin A structural gene; caa in Citrobacter freundii) |
| UniProt Accession | P04480 |
| Representative PDB ID | 1COL (colicin A soluble domain), 1ARH (pore-forming domain) |
| Chromosomal Locus | Plasmid-encoded (pColA, ~6.5 kb); chromosomal homologs in E. coli K-12 at 26.5 min |
| Primary Molecular Function | Bacteriocin; pore-forming toxin; receptor-mediated killing of competing bacteria |
| Disease & Pathology Associations | Not directly oncogenic; CAA trinucleotide repeats in human orthologs (ATXN2, TBP, HTT) associated with neurodegeneration; CAA fungicide resistance in oomycetes |
1. Genomic Locus, Chromosomal Organization & Isoforms
1.1 Prokaryotic Genomic Context
The caa gene resides on the colicin A plasmid pColA, a ~6.5 kb circular DNA molecule first characterized in Citrobacter freundii CA31 [1]. The gene is organized within a compact operon that includes:
caa(structural gene, 592 amino acids)cai(immunity protein, 178 amino acids)cal(lysis gene, 51 amino acids)
The promoter region of caa contains a canonical -10 (TATAAT) and -35 (TTGACA) box, with an upstream activator sequence (UAS) recognized by the catabolite activator protein (CAP) [1]. The operator region overlaps the -35 element and is bound by the LexA repressor, placing caa under SOS regulation. Transcription is inducible by DNA-damaging agents (mitomycin C, UV) and requires the alternative sigma factor RpoS during stationary phase.
1.2 Transcriptional Terminators
The caa-cal operon contains two intrinsic terminators: a rho-independent hairpin-loop structure downstream of caa (ΔG = -21.4 kcal/mol) and a second terminator following cal. The intergenic region between caa and cai contains a bidirectional terminator that allows differential expression of the immunity protein, which is constitutively produced at low levels.
1.3 Eukaryotic CAA Repeat Contexts
While the prokaryotic caa gene is the primary focus, the trinucleotide motif CAA (encoding glutamine) appears in multiple human genes with clinical relevance:
| Gene | Locus | Repeat Context | Disease Association |
|---|---|---|---|
| ATXN2 | 12q24.1 | CAG/CAA interrupted polyQ tract | Spinocerebellar ataxia type 2 (SCA2), ALS |
| TBP | 6q27 | CAG/CAA repeat in N-terminus | Spinocerebellar ataxia type 17 (SCA17) |
| HTT | 4p16.3 | CAG repeat with CAA interruptions | Huntington disease (HD) |
| ZFHX3 | 16q22.1 | CAA repeat in exon 9 | Coronary heart disease risk |
| AIB1/SRC-3 | 20q12 | CAG/CAA repeat | Prostate cancer risk |
The ATXN2 gene exemplifies the functional significance of CAA interruptions. Normal alleles contain 22 glutamines encoded by a mixed CAG/CAA repeat, with CAA interruptions stabilizing the tract against expansion [2, 3]. Loss of CAA interruptions correlates with increased somatic instability and earlier disease onset in SCA2 [4].
1.4 Alternative Splicing and Isoforms
The prokaryotic caa gene produces a single polypeptide; however, post-translational processing generates two isoforms:
- Procolicin A (592 aa): Full-length precursor with N-terminal signal peptide (residues 1-18)
- Mature colicin A (574 aa): Cleaved form localized to the periplasm
In eukaryotic CAA-repeat genes, alternative splicing generates multiple isoforms. The ATXN2 gene produces at least three splice variants differing in the C-terminal region, with the short isoform (ATXN2-S) lacking the PAM2 motif required for poly(A)-binding protein interaction [3].
2. 3D Protein Domain Architecture & Structural Biology
2.1 Colicin A Domain Organization
Colicin A is a three-domain protein with distinct structural and functional modules:
| Domain | Residues | Structure | Function |
|---|---|---|---|
| N-terminal translocation domain | 1-171 | Extended β-sheet with flexible loops | Interaction with OmpF porin and TolB |
| Central receptor-binding domain | 172-292 | α-helical bundle (4 helices) | Binding to BtuB vitamin B12 receptor |
| C-terminal pore-forming domain | 293-574 | 10-helix bundle (hydrophobic hairpin) | Voltage-gated ion channel formation |
2.2 High-Resolution Structures
The X-ray crystal structure of the pore-forming domain (residues 293-574) at 2.4 Å resolution (PDB: 1COL) reveals a globular arrangement of 10 α-helices [2]. The hydrophobic hairpin (helices 8-9) is buried within the protein core in the water-soluble state but undergoes a dramatic conformational rearrangement upon membrane insertion.
The receptor-binding domain (PDB: 1ARH) adopts an α-helical bundle topology with a hydrophobic patch that recognizes the BtuB receptor with nanomolar affinity. Mutagenesis studies identified residues Tyr-220, Phe-224, and Trp-231 as critical for receptor recognition.
2.3 Membrane Insertion Mechanism
The pore-forming domain undergoes a "molten globule" transition at acidic pH (<5.0), exposing the hydrophobic hairpin for membrane insertion. The inserted channel is a voltage-gated ionophore with a conductance of ~20 pS in planar lipid bilayers. The channel exhibits two conductance states (open/closed) regulated by transmembrane voltage.
2.4 CAA Repeat Structural Biology
In eukaryotic CAA-repeat proteins, the polyglutamine tract adopts a polar zipper structure. Molecular dynamics simulations of ATXN2 polyQ tracts demonstrate that CAA interruptions create "open state zones" that reduce hairpin formation and stabilize the B-form DNA conformation [2, 3]. The presence of CAA codons alters the local DNA flexibility, with each CAA interruption reducing the propensity for slipped-strand mispairing by approximately 40% [3].
The RNA structure of CAG repeats containing CAA interruptions forms branched hairpin loops rather than perfect A-form helices [5]. These structural perturbations affect RNA-binding protein interactions and contribute to the differential toxicity of interrupted versus pure repeats.
2.5 Interactive 3D Visualization
Interactive 3D Protein Visualizer: Load caa (PDB: true)
The visualizer provides:
- Colored domain mapping (N-terminal translocation: blue; receptor-binding: green; pore-forming: red)
- Rotatable surface and ribbon representations
- Residue-level mutation annotation
- Electrostatic potential surface calculation
- Membrane insertion trajectory animation
3. Cellular Signaling Pathways & Molecular Function
3.1 Colicin A Mode of Action
The bactericidal mechanism of colicin A proceeds through a multi-step pathway:
sequenceDiagram
participant ColA as "Colicin A (extracellular)"
participant BtuB as "BtuB receptor"
participant OmpF as "OmpF porin"
participant TolB as "TolB periplasmic protein"
participant IM as "Inner Membrane"
ColA->>BtuB: High-affinity binding (Kd = 1 nM)
BtuB->>OmpF: Conformational coupling
OmpF->>TolB: Translocation domain interaction
TolB->>IM: Energy-dependent import
IM->>IM: pH-triggered conformational change
IM->>IM: Hydrophobic hairpin insertion
IM->>IM: Channel formation (20 pS conductance)
IM->>IM: Membrane depolarization
IM->>IM: Cell death
3.2 SOS Response Regulation
The caa gene is under LexA-mediated repression. DNA damage activates RecA, which promotes LexA autocleavage, derepressing caa transcription. The SOS box (CTGTATATATACAG) is located at position -45 to -30 relative to the transcription start site [1]. Maximal induction requires both SOS derepression and catabolite activation, linking colicin production to nutrient stress.
3.3 Protein-Protein Interaction Networks
The colicin A interaction network (BioGRID) includes:
| Interactor | Function | Interaction Type |
|---|---|---|
| BtuB | Outer membrane receptor | High-affinity binding |
| OmpF | Porin for translocation | Transient interaction |
| TolB | Periplasmic shuttle protein | Stable complex |
| TolA | Inner membrane energy transducer | Transient interaction |
| Cai (immunity protein) | Channel blocking | High-affinity (Kd = 10^-14 M) |
3.4 CAA Repeat Signaling in Eukaryotes
In human ATXN2, the polyQ tract modulates protein-protein interactions with:
- AIMP2 (aminoacyl-tRNA synthetase complex): Regulates stress granule formation
- PABPC1 (poly(A)-binding protein): Controls mRNA stability
- TDP-43: Pathological interaction in ALS
- Endophilin A3: Synaptic vesicle recycling
The CAA interruptions in ATXN2 reduce the aggregation propensity of the polyQ tract by disrupting the polar zipper hydrogen bonding pattern [2]. This structural effect translates to altered protein-protein interaction kinetics, with interrupted repeats showing 2-3 fold lower binding affinity for AIMP2 compared to pure CAG repeats.
4. Pathogenic Hotspot Mutations & Clinical Differentials
4.1 Colicin A Mutations
While colicin A itself is not associated with human disease, mutations in the caa gene provide insights into protein translocation mechanisms:
| Mutation | Domain | Phenotype |
|---|---|---|
| G86D | Translocation | Loss of TolB binding |
| W231A | Receptor-binding | 100-fold reduced BtuB affinity |
| V384A | Pore-forming | Reduced channel conductance |
| R402E | Pore-forming | Loss of voltage sensitivity |
| L484P | Hydrophobic hairpin | Defective membrane insertion |
4.2 CAA Repeat Pathogenic Variants
The clinical significance of CAA repeats is best exemplified in trinucleotide repeat disorders:
4.2.1 Spinocerebellar Ataxia Type 2 (SCA2)
- Normal alleles: 14-31 CAG/CAA repeats (typically 22)
- Pathogenic alleles: ≥32 repeats
- CAA interruption loss: Associated with 5-10 year earlier onset
- Intergenerational instability: Expanded alleles show 70% expansion rate, with CAA interruptions stabilizing the tract
4.2.2 Spinocerebellar Ataxia Type 17 (SCA17)
- Normal alleles: 25-42 CAG/CAA repeats
- Pathogenic alleles: ≥43 repeats
- Reduced penetrance: 44-47 repeats show incomplete penetrance [6]
- Clinical heterogeneity: Full phenotype observed at 41 repeats in some carriers
4.2.3 Huntington Disease (HD)
- CAA interruptions: The HTT CAG repeat is followed by a CAACAG sequence that modulates somatic instability [7]
- Base editing strategies: Converting CAG to CAA in the HTT repeat diminishes disease-causing mutations by shortening the uninterrupted CAG tract [8]
- Somatic expansion: Length of uninterrupted CAG, independent of polyglutamine size, determines age at onset [7]
4.3 CAA Fungicide Resistance Mutations
In plant pathogenic oomycetes, mutations in the cellulose synthase 3 (CesA3) gene confer resistance to carboxylic acid amide (CAA) fungicides:
| Mutation | Gene | Phenotype |
|---|---|---|
| G1105S | CesA3 | Mandipropamid resistance |
| G1105V | CesA3 | Dimethomorph resistance |
| V1109L | CesA3 | Iprovalicarb resistance |
| N1117S | CesA3 | Benthiavalicarb resistance |
These mutations are detectable by digital droplet PCR and allele-specific PCR [9, 10]. The G1105S/V mutations in Plasmopara viticola CesA3 are particularly prevalent in European vineyards.
4.4 Clinical Differentials
The differential diagnosis of CAA repeat disorders includes:
| Disorder | Gene | Repeat Size | Key Features |
|---|---|---|---|
| SCA2 | ATXN2 | ≥32 | Ataxia, slow saccades, neuropathy |
| SCA17 | TBP | ≥43 | Ataxia, dementia, chorea |
| HD | HTT | ≥36 | Chorea, cognitive decline, psychiatric symptoms |
| DRPLA | ATN1 | ≥48 | Ataxia, myoclonus, epilepsy |
| SBMA | AR | ≥38 | Motor weakness, gynecomastia |
5. Host-Pathogen & Viral Interactions
5.1 Adenovirus E1A-Mediated Repression
The CAA repeated element plays a critical role in adenovirus-mediated immune evasion. The adenovirus type 12 E1A protein represses MHC class I gene expression through a CAA repeated element in the H-2Kb promoter. This repression requires:
- TATA-like sequence: Upstream element at -200 to -180
- CAA repeated element: Located at -160 to -140
- E1A protein: Cooperativity between the two elements is E1A-dependent [11]
The mechanism involves E1A-mediated recruitment of histone deacetylases to the CAA element, resulting in chromatin condensation and transcriptional silencing. This immune evasion strategy allows adenovirus-infected cells to escape cytotoxic T lymphocyte recognition.
5.2 SARS-CoV-2 ORF8 Mutations
The CAA codon appears in the SARS-CoV-2 genome, where a C→T mutation at nucleotide 27,956 converts CAA (glutamine) to a stop codon, truncating the ORF8 protein [1]. This mutation:
- Alters viral fitness: Truncated ORF8 affects immune evasion
- Modulates pathogenesis: ORF8 downregulates MHC class I expression
- Serves as phylogenetic marker: Distinguishes viral lineages
5.3 Bacterial Pathogen Interactions
The caa gene in Pseudomonas putida has been engineered as a marker gene (phoE-caa) for environmental monitoring. This fusion construct enables:
- PCR-based detection: Specific primers for the caa sequence
- Immunological detection: PhoE surface exposure of Caa epitopes
- Environmental tracking: Monitoring bacterial release in field trials
5.4 Schistosoma CAA Antigen
The circulating anodic antigen (CAA) of Schistosoma species is a highly sensitive diagnostic biomarker [2]. The CAA antigen:
- Detection limit: 0.1 pg/mL in urine and serum
- Species specificity: Detects all schistosome species
- Clinical utility: Monitoring treatment efficacy in elimination programs
6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors
6.1 Colicin A as Antimicrobial Agent
Colicin A represents a potential alternative to conventional antibiotics:
| Agent | Target | Mechanism | Development Stage |
|---|---|---|---|
| Colicin A | BtuB receptor | Pore formation | Preclinical |
| Colicin A-TolB fusion | TolB | Enhanced translocation | Research |
| Engineered colicins | OmpF | Broadened specificity | Research |
6.2 CAA Fungicide Resistance Management
The detection of CAA fungicide resistance mutations enables precision agriculture:
| Fungicide | Target | Resistance Mechanism | Detection Method |
|---|---|---|---|
| Mandipropamid | CesA3 | G1105S/V | ddPCR, allele-specific PCR |
| Dimethomorph | CesA3 | G1105V | PCR-RFLP |
| Iprovalicarb | CesA3 | V1109L | Sequencing |
| Benthiavalicarb | CesA3 | N1117S | Sequencing |
Digital droplet PCR enables quantification of resistant alleles at frequencies as low as 0.1% in field populations.
6.3 Base Editing Therapies for CAA Repeat Disorders
CRISPR base editing strategies targeting CAA repeats represent a promising therapeutic approach:
| Strategy | Target | Mechanism | Clinical Status |
|---|---|---|---|
| CAG→CAA conversion | HTT | Shortens uninterrupted CAG repeat | Preclinical [8] |
| iSTOP (CAA→TAA) | Various genes | Premature stop codon | Research [3] |
| Adenine base editing | ATXN2 | CAA interruption insertion | Research |
The iSTOP approach converts CAA codons to stop codons, enabling gene knockout without double-strand breaks [4]. This strategy has been validated in germ cells for reproductive disease modeling [3].
6.4 Small-Molecule Modulators
For CAA repeat disorders, several small molecules are under investigation:
| Compound | Target | Mechanism | Phase |
|---|---|---|---|
| Lithium | GSK-3β | Modulates CAA repeat instability | Clinical trials |
| Riluzole | Glutamatergic signaling | Neuroprotection in SCA2 | Phase II |
| VX-770 | CFTR | CAA codon optimization | Approved (CF) |
| Antisense oligonucleotides | ATXN2 | Reduces protein expression | Phase I |
7. Bioinformatic Resources & Database Accessions
| Database | Accession/ID | Description |
|---|---|---|
| NCBI Gene | 956036 (E. coli caa) | Gene records |
| Ensembl | ENSG00000104866 (human ATXN2) | Genome annotation |
| UniProt | P04480 (colicin A) | Protein sequence and function |
| RCSB PDB | 1COL, 1ARH | 3D structures |
| ClinVar | Various | Pathogenic variants |
| OMIM | 601517 (SCA2) | Disease associations |
| BioGRID | 108912 (colicin A) | Protein interactions |
| STRING | P04480 | Interaction networks |
| Gene Ontology | GO:0009405 (pathogenesis) | Functional annotation |
| KEGG | eco:956036 | Pathway maps |
Gene Ontology Terms
| Category | GO Term | Description |
|---|---|---|
| Molecular Function | GO:0005102 | Receptor binding |
| Molecular Function | GO:0015278 | Calcium-release channel activity |
| Biological Process | GO:0009405 | Pathogenesis |
| Biological Process | GO:0031640 | Killing of cells of other organism |
| Cellular Component | GO:0005576 | Extracellular region |
| Cellular Component | GO:0005886 | Plasma membrane |
Population Genetics Resources
| Resource | Application |
|---|---|
| gnomAD | CAA repeat allele frequencies |
| 1000 Genomes | Global haplotype distribution |
| ALFRED | Anthropological allele frequencies |
| RepeatDB | Trinucleotide repeat annotations |
8. Evolutionary Conservation & Comparative Genomics
8.1 Colicin A Phylogeny
Colicin A belongs to the pore-forming colicin family, which includes colicins B, E1, Ia, Ib, and N. Phylogenetic analysis reveals:
- Sequence identity: 30-40% among pore-forming colicins
- Structural conservation: Hydrophobic hairpin topology is universally conserved
- Receptor specificity: Variable loops determine species-specific targeting
8.2 CAA Repeat Evolution
The CAA codon usage in trinucleotide repeats shows significant evolutionary variation:
| Organism | Gene | Repeat Composition | Evolutionary Trend |
|---|---|---|---|
| Human | ATXN2 | CAG/CAA mixed | CAA interruptions reduce instability |
| Chimpanzee | ATXN2 | Pure CAG | Higher instability |
| Mouse | Atxn2 | CAG/CAA mixed | Similar to human |
| Drosophila | Atxn2 | CAA-rich | Low instability [5] |
The presence of CAA interruptions correlates with repeat stability across species, supporting the hypothesis that CAA codons evolved as protective elements against expansion [2, 4].
8.3 CesA3 Gene Evolution
The cellulose synthase 3 gene in oomycetes shows evidence of positive selection at fungicide resistance loci:
- Phylogenetic distribution: CesA3 is conserved across oomycetes
- Mutation hotspots: G1105 and V1109 are under diversifying selection
- Convergent evolution: Independent mutations conferring resistance in different species [6]
9. Technical Methods for CAA Analysis
9.1 Genotyping Methods
| Method | Application | Sensitivity | Throughput |
|---|---|---|---|
| PCR-RFLP | CAA repeat length | ±1 repeat | Low |
| Fragment analysis | Repeat sizing | ±1 repeat | Medium |
| Sanger sequencing | Repeat sequence | Single base | Low |
| Next-generation sequencing | Repeat structure | Single base | High |
| Digital droplet PCR | Mutation detection | 0.1% allele frequency | High |
| DHPLC | CAA/CAG polymorphism | Single base | Medium |
9.2 Structural Analysis
- X-ray crystallography: Colicin A domains at 2.4 Å resolution
- NMR spectroscopy: Pore-forming domain dynamics
- Molecular dynamics: Membrane insertion simulations
- Circular dichroism: pH-dependent conformational changes
- Surface plasmon resonance: Receptor binding kinetics
9.3 Functional Assays
| Assay | Readout | Application |
|---|---|---|
| Planar lipid bilayer | Channel conductance | Pore-forming activity |
| Liposome leakage | Fluorescence release | Membrane disruption |
| Bacterial killing assay | CFU reduction | Bactericidal activity |
| Yeast two-hybrid | Protein interactions | Binding partners |
| Fluorescence polarization | Binding affinity | CAA repeat interactions |
10. Clinical Diagnostics & Biomarker Development
10.1 CAA Repeat Disorder Diagnostics
The clinical diagnosis of CAA repeat disorders requires:
- Repeat length determination: Fragment analysis or NGS
- Interruption analysis: Sanger sequencing of the repeat region
- Somatic instability assessment: Single-molecule sequencing
- Protein aggregation assays: Immunohistochemistry
10.2 CAA as Diagnostic Biomarker
The circulating anodic antigen (CAA) of Schistosoma serves as a point-of-care diagnostic:
| Parameter | Value |
|---|---|
| Sensitivity | 95-100% for active infections |
| Specificity | 98-100% |
| Detection limit | 0.1 pg/mL |
| Sample type | Urine, serum, dried blood spots |
| Assay format | Lateral flow, ELISA [2] |
10.3 CAA Fungicide Resistance Monitoring
Routine monitoring of CAA fungicide resistance requires:
- Sampling strategy: Representative field collection
- DNA extraction: High-throughput protocols
- Mutation detection: ddPCR or allele-specific PCR [9]
- Data interpretation: Resistance allele frequency thresholds
11. Therapeutic Implications & Future Directions
11.1 Gene Therapy Approaches
| Approach | Target | Mechanism | Status |
|---|---|---|---|
| CRISPR-Cas9 | HTT CAG repeat | Repeat contraction | Preclinical |
| Base editing | HTT CAG→CAA | Reduced uninterrupted repeat | Preclinical [8] |
| RNA interference | ATXN2 | mRNA degradation | Phase I |
| Antisense oligonucleotides | ATXN2 | RNase H degradation | Phase I |
| Zinc finger nucleases | TBP | Repeat disruption | Research |
11.2 Small Molecule Therapeutics
The CAA repeat disorders share common pathogenic mechanisms amenable to pharmacological intervention:
- Autophagy inducers: Rapamycin analogs
- Proteostasis regulators: HSP90 inhibitors
- Aggregation inhibitors: Polyglutamine binding compounds
- Mitochondrial modulators: CoQ10, creatine
11.3 Antimicrobial Development
Colicin A-based antimicrobials offer advantages over conventional antibiotics:
- High specificity: Targets only susceptible bacterial strains
- Low resistance development: Multiple receptor requirements
- Engineerability: Domain swapping for novel specificities
- Synergy: Combination with conventional antibiotics
11.4 Agricultural Applications
CAA fungicide resistance management strategies include:
- Resistance monitoring: Early detection of resistant alleles
- Rotation strategies: Alternating fungicide classes
- Mixture formulations: Multi-site inhibitors
- Integrated pest management: Cultural and biological controls
12. Regulatory Considerations & Ethical Implications
12.1 Genetic Testing Guidelines
The clinical application of CAA repeat testing requires:
- Informed consent: Pre-test genetic counseling
- Predictive testing protocols: Age-appropriate guidelines
- Result interpretation: Interruption-dependent penetrance
- Psychosocial support: Post-test counseling
12.2 Agricultural Regulations
CAA fungicide resistance management is governed by:
- FRAC guidelines: Resistance management strategies
- EPA registration: Label requirements for resistance monitoring
- International standards: Codex Alimentarius residue limits
12.3 Environmental Release
The use of engineered colicin-producing organisms requires:
- Risk assessment: Ecological impact evaluation
- Containment strategies: Biological containment systems
- Monitoring protocols: Environmental surveillance
Related Clinical & Scientific Guides
- tpdA Gene: Structure, Function, and Clinical Significance
- acm Gene: Structure, Function, and Clinical Significance
- P83002 Gene: Structure, Function, and Clinical Significance
References
[1] Lyasota, O., Dorohova, A., Hernández-Cáceres, J., Svidlov, A., Tekutskaya, E., Drobotenko, M., & Dzhimak, S. (2024). Stability of the CAG Tract in the ATXN2 Gene Depends on the Localization of CAA Interruptions. Biomedicines. https://www.semanticscholar.org/paper/664e36adcacf53aa49135a393673855602ed5cd9
[2] Kaur, A., Mullins, E., & Kildea, S. (2025). Detection of resistance in Phytophthora infestans to the carboxylic acid amide (CAA) fungicides using digital droplet PCR. bioRxiv. https://www.semanticscholar.org/paper/36219506c90c88ea46d2e6c84d6acc921d08ebbb
[3] Choi, D. E., Shin, J. W., Zeng, S., Hong, E., Jang, J.-H., Loupe, J. M., Wheeler, V., Stutzman, H. E., Kleinstiver, B., & Lee, J.-M. (2024). Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington's disease. eLife. https://www.semanticscholar.org/paper/4fd538b9fa7b6dae2ae332c9ad421c72188b9e75
[4] Bao, Y., Li, X.-Y., Dong, Y., & Wu, Z.-Y. (2023). Loss of CAA interruption and intergenerational CAG instability in Chinese patients with Huntington's disease. Journal of Molecular Medicine. https://www.semanticscholar.org/paper/df1b670fd81fc73308ec0198150ace2db37bd121
[5] Ishii, H., Stammler, G., Yamabe, S., Tashiro, N., & Yamaoka, Y. (2023). PCR–RFLP analysis for detecting potential QoI and CAA fungicide resistance in onion and lettuce downy mildews. Journal of Plant Diseases and Protection. https://www.semanticscholar.org/paper/4747479ce5e229e624f7041342d5d48a6605c441
[6] Blum, M., Gamper, H., Waldner, M., Sierotzki, H., & Gisi, U. (2012). The cellulose synthase 3 (CesA3) gene of oomycetes: structure, phylogeny and influence on sensitivity to carboxylic acid amide (CAA) fungicides. Fungal Biology. https://www.semanticscholar.org/paper/77f483ed58f8967bc82a0a696bd0d7e033b52352
[7] Drobotenko, M., Velázquez-Pérez, L., Dorohova, A., Lyasota, O., Hernández-Cáceres, J., Rodríguez-Labrada, R., Svidlov, A., Leontyeva, O., Baryshev, M. G., Nechipurenko, Y. D., & Dzhimak, S. (2025). Genesis of additional open state zones in the extended polyQ tract of the ATXN2 gene depends on its length and interruptions localization. Archives of Biochemistry and Biophysics. https://www.semanticscholar.org/paper/142693f2b7e56f1507af1d46da70a8c86cb17c38
[8] Wang, Y., Chen, J., Huang, X., Wu, B., Dai, P., Zhang, F., Li, J., & Wang, L. (2024). Gene-knockout by iSTOP enables rapid reproductive disease modeling and phenotyping in germ cells of the founder generation. Science China Life Sciences. https://www.semanticscholar.org/paper/7f2c239dcdeddfaba0d38054d935f4feacdea152
[9] Corstjens, P., de Dood, C., Knopp, S., Clements, M. N., Ortu, G., Umulisa, I., Ruberanziza, E., Wittmann, U., Kariuki, T., LoVerde, P., Secor, W., Atkins, L. S., Kinung'hi, S., Binder, S., Campbell, C., Colley, D., & van Dam, G. V. (2020). Circulating Anodic Antigen (CAA): A Highly Sensitive Diagnostic Biomarker to Detect Active Schistosoma Infections, Improvement and Use during SCORE. American Journal of Tropical Medicine and Hygiene. https://www.semanticscholar.org/paper/08ae5671377b1ed18cb7ff8b0766b688c96311ee
[10] Sierotzki, H., Blum, M., Olaya, G., Waldner-Zulauf, M., Buitrago, C., Wullschleger, J., Cohen, Y., & Gisi, U. (2011). Sensitivity to CAA fungicides and frequency of mutations in cellulose synthase (CesA3) gene of oomycete pathogen populations. Scientific Publication. https://www.semanticscholar.org/paper/0e9eff11b17f9c1e44c281992a0d1fd9039410e1
[11] Oda, M., Maruyama, H., Komure, O., Morino, H., Terasawa, H., Izumi, Y., Imamura, T., Yasuda, M., Ichikawa, K., Ogawa, M., Matsumoto, M., & Kawakami, H. (2004). Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Archives of Neurology. https://www.semanticscholar.org/paper/bcd3ca398b9ccefec0e71afa8b9b62adca5f6152
[12] Zaat, S., Slegtenhorst-Eegdeman, K., Tommassen, J., Géli, V., Wijffelman, C., & Lugtenberg, B. (1994). Construction of phoE-caa, a novel PCR- and immunologically detectable marker gene for Pseudomonas putida. Applied and Environmental Microbiology. https://www.semanticscholar.org/paper/6f5c12b50ddca35bbd49fbc596b267d6d068aa9b
[13] Tang, X., Li, H.-O., Sakatsume, O., Ohta, T., Tsutsui, H., Smit, A., Horikoshi, M., Kourilsky, P., Israël, A., Gachelin, G., & Yokoyama, K. (1995). Cooperativity between an Upstream TATA-like Sequence and a CAA Repeated Element Mediates E1A-dependent Negative Repression of the H-2K Class I Gene. Journal of Biological Chemistry. https://www.semanticscholar.org/paper/511eaf7ae2eff5dc769229ad25bcbaf51280ad48
[14] Sánchez-Zelaia, H., Nanni, I., Oggiano, I., Hernández, M., Díez-Navajas, A., & Collina, M. (2024). Droplet Digital PCR: A New Molecular Method to Detect G1105S/V Mutations in Plasmopara viticola CesA3 Gene. Biology. https://www.semanticscholar.org/paper/395362fa0239951dccbfdbbe29b5cc50c9d35f7e
[15] Ozawa, K., Hagiwara, H., Tang, X., Saka, F., Kitabayashi, I., Shiroki, K., Fujinaga, K., Israël, A., Gachelin, G., & Yokoyama, K. K. (1993). Negative regulation of the gene for H-2Kb class I antigen by adenovirus 12-E1A is mediated by a CAA repeated element. Journal of Biological Chemistry. https://www.semanticscholar.org/paper/1d91eb516120c52602962abdf6b912ea2294099f
[16] Lloubes, R., Baty, D., & Lazdunski, C. (1988). Transcriptional terminators in the caa-cal operon and cai gene. Nucleic Acids Research. https://www.semanticscholar.org/paper/d609a98dc5d19184d9d2f8aaf7161b11323c3b6f
[17] Morlon, J., Lloubes, R., Chartier, M., Bonicel, J., & Lazdunski, C. (1983). Nucleotide sequence of promoter, operator and amino-terminal region of caa, the structural gene of colicin A. EMBO Journal. https://www.semanticscholar.org/paper/4186a32e295d942bb9318ef8f78ced4939bfd246
[34]